James J. Martin Appointed as Chief Financial Officer of Cocrystal Pharma, Inc.
Sign up for email alerts
Be the first to receive breaking newsSign up today
Cocrystal Pharma, Inc. is a pharmaceutical company with a mission to discover novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. Cocrystal Pharma employs unique nucleoside chemistry and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. These technologies and our market-focused approach to drug discovery are designed to efficiently deliver small molecule therapeutics that are safe, effective and convenient to administer.